
COVID-19
-
Cancer & COVID-19 Risk: A Q&A with Dr. Gary LymanAnyone exposed to COVID-19 is at risk of infection, but people with cancer are at increased risk of infection, severe complications and death…
-
NIH Study Gathers Data on COVID-19 Immunity, PrevalenceA nationwide National Institutes of Health (NIH) study hopes to gather data on COVID-19 antibodies to shed light on how many…Michelle Llamas, BCPA October 6, 2020
-
COVID-19 Testing: Your Questions AnsweredCommunities across the U.S. continue to reopen, and more people may find themselves in need of COVID-19 testing. Right now, there are…Michelle Llamas, BCPA August 17, 2020
-
DOJ, 3M Crack Down on COVID-19 Price GougingA New York man became the first person federally charged with hoarding and reselling tons of “COVID-19 essentials” at a huge markup,…Michelle Llamas, BCPA May 12, 2020
-
COVID-19-Related Class Action Lawsuits on the RiseAs COVID-19 case numbers climb across the United States, so do the numbers of class action lawsuits for consumer fraud, misleading…Michelle Llamas, BCPA April 29, 2020
-
Vetting a COVID-19 Drug: A Q&A with Immunologist Dr. Hooman NoorchashmAs the global count of COVID-19 cases continues to climb, researchers, scientists and drug makers are working quickly to find a potential treatment.Michelle Llamas, BCPA April 28, 2020
Who Am I Calling?
Calling this number connects you with a Drugwatch representative. We will direct you to one of our trusted legal partners for a free case review.
Drugwatch's trusted legal partners support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.
(888) 645-1617